Naturhouse Health SA (NTH)
Madrid Exchange · Spain · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 2.230 |
|---|---|
| 52-week range | 1.850 – 2.820 |
| Return, 1 month / 3 months | −7.5% / −11.5% |
| Return, 1 year / 3 years | +10.2% / +87.6% |
| Trend | Below its 200-day average |
| RSI (14) | 45 |
| Volatility (1 year) | 25.1% |
| Worst drawdown (1 year) | -21.5% |
| Average daily value traded | 0.09M EUR |
| Dividend yield | 10.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Naturhouse Health is a Spanish company that runs a network of franchised centres offering weight-management and nutrition advice. Its staff provide personalised diet plans and counselling to customers who want to lose weight or improve their eating habits. The centres also offer the company's own food supplements and diet products, which customers use alongside the guidance they receive. The business is based in Spain and operates through franchise partners in several countries.
Naturhouse Health SA trades under the code NTH on the Madrid Exchange in Spain, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Naturhouse Health SA (NTH) trades on the Madrid Exchange in Spain. It last closed at EUR 2.230 on 22 October 2026.
Its price-based Market X-Ray is 47 out of 100 (a weak price profile), ranking 140 of 236 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 10.2% and over the last three months it fell 11.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Madrid Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 33 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -9.4% | ||
| From 52-week high | -20.1% | ||
| Momentum | 43 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -11.5% | ||
| 6-month return | -11.1% | ||
| 12-month return, skipping the last month | 19.1% | ||
| Stability (higher is calmer) | 48 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 25.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -21.5% | ||
| Liquidity | 60 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.09M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 73 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 10.9% | ||
| Years with dividends | 5 |
Strengths
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +0.9% |
|---|---|
| 1 month | −7.5% |
| 3 months | −11.5% |
| 6 months | −11.1% |
| 1 year | +10.2% |
| 3 years | +87.6% |
| 5 years | +91.6% |
Signals
| 50-day / 200-day average | 2.379 / 2.461 |
|---|---|
| Golden / death cross (60 days) | Death, 11 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.073 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 4 Nov 2026 | EUR 0.0500 |
| 23 Jul 2026 | EUR 0.0405 |
| 16 Apr 2026 | EUR 0.0405 |
| 30 Jan 2026 | EUR 0.0810 |
| 22 Oct 2025 | EUR 0.0810 |
| 3 Jul 2025 | EUR 0.0810 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Madrid Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.